Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases - Cartesian. Learn more
Launch date
Employees
Market cap
€326m
Enterprise valuation
€260m (Public information from Sep 2024)
Share price
$16.54 RNAC
Gaithersburg Maryland (HQ)
Authorizing premium user...